Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene‐covered stents versus bare stents: A meta‐analysis

@article{Yang2010PatencyAC,
  title={Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene‐covered stents versus bare stents: A meta‐analysis},
  author={Zhiping Yang and Guohong Han and Qiong Wu and Xiaofei Ye and Zhi-Chao Jin and Zhanxin Yin and Xingshun Qi and Ming Bai and Kaichun Wu and Daiming Fan},
  journal={Journal of Gastroenterology and Hepatology},
  year={2010},
  volume={25}
}
Background and Aim:  Transjugular intrahepatic portosystemic shunt (TIPS) with polytetrafluoroethylene‐(PTFE)‐covered stent has been increasingly used for patients with complications of portal hypertension. It is still debated whether the new endoprostheses will improve some clinical outcomes (except for shunt patency) compared to the bare stents. The aims of our meta‐analysis were to explore the patency and clinical outcomes of TIPS with PTFE‐covered stent‐grafts versus bare stents. 
View on Wiley
ncbi.nlm.nih.gov
118 Citations
Highly Influential Citations
1
Background Citations
32
Methods Citations
2
Results Citations
7

118 Citations

Citation Type

Citation Type

Erratum to: Comparison of Technical and Clinical Outcome of Transjugular Portosystemic Shunt Placement Between a Bare Metal Stent and a PTFE-Stentgraft Device
Purpose To analyse technical and clinical success of transjugular intrahepatic portosystemic shunt (TIPS) in patients with portal hypertension and compare a stent and a stentgraft with regard to…
Added Value of Covered Stents in Transjugular Intrahepatic Portosystemic Shunt: A Large Single-Center Experience
TLDR
It is demonstrated that covered stents offer the additional value of higher estimated overall survival and higher estimated survival in patients undergoing TIPS emergently and in those with higher MELD scores when compared to uncovered stents.
Transjugular intrahepatic portosystemic shunt.
Using transjugular intrahepatic portosystemic shunts for complications of cirrhosis.
  • H. Bhogal, A. Sanyal
  • Medicine
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2011
Stent Dysfunction After Transjugular Intrahepatic Portosystemic Shunt: A 14-Year Experience from a Single Tertiary Medical Center
TLDR
TIPS created with segmental portal venous access has superior patency over that of TIPS with portal trunk access, however, there was no significant difference in patient survival, worsening of encephalopathy, or major complications between segmental access and portal trunkAccess.
Transjugular intrahepatic portosystemic shunt in combination with or without variceal embolization for the prevention of variceal rebleeding: A meta‐analysis
TLDR
A meta‐analysis to compare the incidence of shunt dysfunction, variceal rebleeding, encephalopathy, and death between patients treated withTIPS alone and those treated with TIPS combined withvariceal embolization was conducted.
A new choice of stent for transjugular intrahepatic portosystemic shunt creation: Viabahn ePTFE covered stent/bare metal stent combination
Covered versus bare stents for transjugular intrahepatic portosystemic shunt: an updated meta-analysis of randomized controlled trials
TLDR
Compared with bare stents, covered stents for TIPS may improve the overall survival and in the era of covered stent, the indications forTIPS may be further expanded.
Polytetrafluoroethylene-Covered Stent Graft Versus Bare Stent in Transjugular Intrahepatic Portosystemic Shunt: Systematic Review and Meta-Analysis.
TLDR
CS is associated with better primary patency and survival and lesser rate of rebleeding than BS in patients undergoing TIPS procedure and there is no difference in new-onset hepatic encephalopathy.
Comparison of Technical and Clinical Outcome of Transjugular Portosystemic Shunt Placement Between a Bare Metal Stent and a PTFE-Stentgraft Device
TLDR
TIPS is a safe and effective procedure to manage portal hypertension and Stent and stentgraft enabled good technical and clinical results with a low complication rate, whereas the stent was more cost effective with similar clinical results in both groups.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 43 REFERENCES
Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents
TLDR
The Viatorr type of polytetrafluoroethylene-covered stent results in vastly improved patency compared with uncovered stents, with reduced rates of variceal rebleeding and hepatic encephalopathy.
Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents.
Causes of TIPS dysfunction.
TLDR
The use of an expandable polytetrafluoroethylene (PTFE)-covered-stent has significantly improved TIPS patency and the need for follow-up venography and secondary interventions has been reduced significantly as a result of improved shunt patency.
Transjugular intrahepatic portosystemic stent-shunt: technical factors and new developments
TLDR
Cover stents are now widely used and have the potential to drastically reduce shunt insufficiency, the need for long-term shunt surveillance and even hepatic encephalopathy.
Management of shunt dysfunction in the era of TIPS endografts.
  • T. Clark
  • Medicine
    Techniques in vascular and interventional radiology
  • 2008
TLDR
Significantly improved long-term patency can be achieved with transjugular intrahepatic portosystemic shunt (TIPS) endografts compared to conventional bare stents, but distinct patterns of dysfunction can occur with TIPS endOGrafts.
PTFE‐covered stents improve TIPS patency in Budd‐Chiari syndrome
TLDR
PTFE‐covered stents have a considerable advantage over bare stents for the TIPS treatment of BCS patients, with a lower dysfunction rate, a lower number of reinterventions, and fewer prosthesis requirements.
Improved transjugular intrahepatic portosystemic shunt patency with PTFE-covered stent-grafts: experimental results in swine.
TLDR
PTFE-covered stent-grafts significantly improved TIPS patency in swine (P < .01), however, stenosis in the hepatic vein led to late shunt malfunction in selected cases.
Improved patency of transjugular intrahepatic portosystemic shunts in humans: creation and revision with PTFE stent-grafts.
TLDR
PTFE stent-grafts can markedly prolong TIPS patency, potentially reducing the need for shunt follow-up and revision and the risk of recurrent symptoms associated with shunt stenosis or occlusion.
Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE‐covered stentgrafts versus bare stents
TLDR
Patients undergoing ePTFE‐endoprosthesis implantation had higher survival rates within 2 years after TIPS‐implantation, which may be the result of improved patency rates after correct placement (up to the inferior caval vein [ICV]) of the eP TFE stentgraft.
[Transjugular intrahepatic portosystemic shunt (TIPS)].
...
1
2
3
4
5
...